Probing the time variability of five Fe low broad absorption line quasars

We study the time variability of five Fe Low ionization Broad Absorption Line (FeLoBAL) QSOs using repeated spectroscopic observations with the 2m telescope at IUCAA Girawali observatory (IGO) spanning an interval of upto 10 years. We report a dramatic variation in Al III and Fe III fine-structure lines in the spectra of SDSS J221511.93-004549.9 (z_em ~ 1.478). However, there is no such strong variability shown by the C IV absorption. This source is known to be unusual with (i) the continuum emission dominated by Fe emission lines, (ii) Fe III absorption being stronger than Fe II and (iii) the apparent ratio of Fe III UV 48 to Fe III UV 34 absorption suggesting an inverted population ratio. This is the first reported detection of time variability in the Fe III fine-structure lines in QSO spectra. There is a strong reduction in the absorption strength of these lines between year 2000 and 2008. Using the template fitting techniques, we show that the apparent inversion of strength of UV lines could be related to the complex spectral energy distribution of this QSO. The observed variability can be related to change in the ionization state of the gas or due to transverse motion of this absorbing gas. The shortest variability timescale of Al III line gives a lower limit on the electron density of the absorbing gas as n_e >= 1.1 x 10^4 cm^-3. The remaining 4 FeLoBALs do not show any changes beyond the measurement uncertainties either in optical depth or in the velocity structure. We present the long-term photometric light curve for all of our sources. Among them only SDSS J221511.93-004549.9 shows significant (>= 0.2 mag) variability.Comment: 15 pages, 9 figures, 3 tables, Accepted for publication in MNRA

Extraction and Physico-Chemical Characterization of Pineapple Crown Leaf Fibers (PCLF)

Apart from the widely discussed pineapple leaf fibers, normally referred to as PALF, fibers from other parts of the plant also exist, particularly those in the fruit crown, which are known as pineapple crown leaf fibers (PCLF). In this work, PCLF were characterized using thermogravimetric analysis (TGA), Fourier transform IR spectroscopy (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM), and atomic force microscopy (AFM). The results indicated that the properties of PCLF do not greatly differ from those observed for PALF. In particular, a cellulose content of over 67% was observed, with approximately 76% crystallinity. The main degradation phenomena of the fibers took place between 230 and 380 degrees C, peaking at 324 degrees C, which is in line with observations in other fibers which have similar cellulose and crystalline contents. There was 13.4% residue at 680 degrees C. Bare mechanical retting of PCLF, although not allowing a full and thorough degumming, which would only be achieved through more aggressive chemical treatment, enabled aspect ratios of over 10(3) to be obtained. This indicates some potential for their application as short fibers in composites. In this respect, the considerable roughness of PCLF when compared to other leaf-extracted fibers, and in particular when compared to PALF, could suggest an ability to obtain a sufficiently sound fiber-matrix interface

Multisoliton solutions and integrability aspects of coupled nonlinear Schrodinger equations

Using Painleve singularity structure analysis, we show that coupled higher-order nonlinear Schrodinger (CHNLS) equations admit Painleve property. Using the results of Painleve analysis, we succeed in Hirota bilinearizing the CHNLS equations, one soliton and two soliton solutions are explictly obtained. Lax pairs are explictly constructed.Comment: Eight pages and six figures. Physical Review E (to be appear

Biology of squids

This section is. based on the data collected in the squid jigging survey made by two vessels, M.F.V. Matsya Sugandhi and M.V. Blue Fin on the southwest coast of India during the 9-month period from June 19&& to February 19&9. The data were collected onboard by the scientists of CMFRI who partici;>ated in the survey. Three species of squids were jigged during the survey, and to understand some aspects of the biology of each of these species a general idea about their distribution and Telative abundance in space and time is necessary. For this' purpose, a one-degree square where jigging was done during the period is taken as a unit area

Fishery, biology and stock structure of skipjack tuna, Katsuwonus pelamis (Linnaeus, 1758) exploited from Indian waters

Global catches of skipjack tuna have been steadily increasing since 1951, reaching a peak in 2009 at 25, 99,681 t (Fig.1). Most of the catches were reported from the fishing areas 71, 51, 61 and 34 (FA0, 2011). Globally skipjack tuna is caught at the surface, mostly with purse seines and pole and lines and to a small extent by gillnets, troll lines and longlines. Gears like purse-seine and very long gillnets enabled few nations to augment their production, whereas traditional pole and line nations suffered heavily

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques

Chronic unresolved inflammation plays a causal role in the development of advanced atherosclerosis, but the mechanisms that prevent resolution in atherosclerosis remain unclear. Here, we use targeted mass spectrometry to identify specialized pro-resolving lipid mediators (SPM) in histologically-defined stable and vulnerable regions of human carotid atherosclerotic plaques. The levels of SPMs, particularly resolvin D1 (RvD1), and the ratio of SPMs to pro-inflammatory leukotriene B4 (LTB₄), are significantly decreased in the vulnerable regions. SPMs are also decreased in advanced plaques of fat-fed Ldlr⁻/⁻ mice. Administration of RvD1 to these mice during plaque progression restores the RvD1:LTB₄ ratio to that of less advanced lesions and promotes plaque stability, including decreased lesional oxidative stress and necrosis, improved lesional efferocytosis, and thicker fibrous caps. These findings provide molecular support for the concept that defective inflammation resolution contributes to the formation of clinically dangerous plaques and offer a mechanistic rationale for SPM therapy to promote plaque stability

EFFICACY AND SAFETY OF EPTACOG BETA (RECOMBINANT HUMAN FVIIA) ACCORDING TO AGE IN PERSONS WITH HAEMOPHILIA A/B WITH INHIBITORS UNDERGOING SURGICAL PROCEDURES

Introduction: Eptacog beta (CEVENFACTA®) is a new rFVIIa approved by the EMA for the treatment of bleeding events and prevention of bleeding during surgery in persons with haemophilia A/B with inhibitors (PwHABI) aged ≥12 years (y). Methods: PERSEPT 3 was a Phase 3 (NCT02020369) trial of eptacog beta in PwHABI who required surgical procedures. Eptacog beta was administered at an initial dose of 200μg/kg or 75μg/kg for major or minor procedures respectively. This was followed by 75μg/kg for ≥5 (major procedures) or ≥2 (minor procedures) days. Haemostatic efficacy was assessed using a 4-point scale during the intra and postoperative care period (primary efficacy endpoint was determined by the investigator at the study centre 48±4h after the last dose of eptacog beta, based on the totality of the assessments performed on the patient (pt) at each timepoint). This post-hoc analysis compared the efficacy and safety of eptacog beta by age (pts aged \u3c12 vs ≥12y). Results: Twelve pts were included (\u3c12y: n=5, 1 major and 4 minor procedures; ≥12y: n=7, 5 major and 2 minor procedures). The primary endpoint success proportion was 100% (95% CI: 39.8-100) in pts aged \u3c12y (4 successes, 1 missing) and 71.4% (95% CI: 29.0-96.3) in pts aged ≥12y (5 successes; 2 failures). The intraoperative success proportion was 100% (95% CI: 47.8-100) for pts aged \u3c12y (5 successes) and 100% (95% CI: 59.0-100) for pts aged ≥12y (7 successes). The success proportion 24h post-procedure was 100% (95% CI: 47.8-100) for pts aged \u3c12y (5 successes) and 100% (95% CI: 47.8-100) for pts aged ≥12y (5 successes; 2 missing). Two pts discontinued treatment (1 aged \u3c12y withdrew consent; 1 aged ≥12y due to an adverse event (AE): postprocedural hematoma). One pt experienced 2 serious AEs leading to death, both were considered unrelated to the treatment. No allergic or thrombotic events occurred; no neutralising antibodies were detected. Antifibrinolytics were used concomitantly with eptacog beta in 4 patients without any safety concerns. Discussion/Conclusion: This post-hoc subgroup analysis shows that eptacog beta is effective and well-tolerated in perioperative care irrespective of patient age (\u3c12 vs ≥12y), supporting the use of eptacog beta for bleed management (prevention and treatment) in major and minor surgical procedures in all PwHABI

A minimal set of internal control genes for gene expression studies in head and neck squamous cell carcinoma

Selection of the right reference gene(s) is crucial in the analysis and interpretation of gene expression data. The aim of the present study was to discover and validate a minimal set of internal control genes in head and neck tumor studies. We analyzed data from multiple sources (in house whole-genome gene expression microarrays, previously published quantitative real-time PCR (qPCR) data and RNA-seq data from TCGA) to come up with a list of 18 genes (discovery set) that had the lowest variance, a high level of expression across tumors, and their matched normal samples. The genes in the discovery set were ranked using four different algorithms (BestKeeper, geNorm, NormFinder, and comparative delta Ct) and a web-based comparative tool, RefFinder, for their stability and variance in expression across tissues. Finally, we validated their expression using qPCR in an additional set of tumor:matched normal samples that resulted in five genes (RPL30, RPL27, PSMC5, MTCH1, and OAZ1), out of which RPL30 and RPL27 were most stable and were abundantly expressed across the tissues. Our data suggest that RPL30 or RPL27 in combination with either PSMC5 or MTCH1 or OAZ1 can be used as a minimal set of control genes in head and neck tumor gene expression studies